Viewing Study NCT02243202


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-02-28 @ 3:31 AM
Study NCT ID: NCT02243202
Status: COMPLETED
Last Update Posted: 2016-10-06
First Post: 2014-09-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
Sponsor: Janssen Research & Development, LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-09
Start Date Type: None
Primary Completion Date: 2015-06
Primary Completion Date Type: ACTUAL
Completion Date: 2015-06
Completion Date Type: ACTUAL
First Submit Date: 2014-09-16
First Submit QC Date: None
Study First Post Date: 2014-09-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2016-06-16
Results First Submit QC Date: None
Results First Post Date: 2016-10-06
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-08-10
Last Update Post Date: 2016-10-06
Last Update Post Date Type: ESTIMATED